Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he will take to ensure that people with underlying health conditions who took part in the Novavax trial can receive a third dose of a covid-19 vaccination.

Novavax trial participants who are part of a priority group, such as health and social care workers, older people and people with certain medical conditions, are able to receive a booster vaccine on top of their trial doses. Individuals will be offered a booster dose by either their clinical trial team or via the National Health Service.